113 related articles for article (PubMed ID: 25997536)
1. Human mesenchymal stem cells enhance cancer cell proliferation via IL-6 secretion and activation of ERK1/2.
Scherzad A; Steber M; Gehrke T; Rak K; Froelich K; Schendzielorz P; Hagen R; Kleinsasser N; Hackenberg S
Int J Oncol; 2015 Jul; 47(1):391-7. PubMed ID: 25997536
[TBL] [Abstract][Full Text] [Related]
2. Human mesenchymal stem cells promote cancer motility and cytokine secretion in vitro.
Scherzed A; Hackenberg S; Radeloff A; Froelich K; Rak K; Hagen R; Kleinsasser N
Cells Tissues Organs; 2013; 198(5):327-37. PubMed ID: 24356396
[TBL] [Abstract][Full Text] [Related]
3. The differentiation of hMSCs counteracts their migration capability and pro-angiogenic effects in vitro.
Scherzed A; Hackenberg S; Froelich K; Rak K; Schendzielorz P; Gehrke T; Hagen R; Kleinsasser N
Oncol Rep; 2016 Jan; 35(1):219-26. PubMed ID: 26530463
[TBL] [Abstract][Full Text] [Related]
4. Head and neck squamous cancer cells enhance the differentiation of human mesenchymal stem cells to adipogenic and osteogenic linages
Meyer TJ; Hackenberg S; Herrmann M; Gehrke T; Steber M; Hagen R; Kleinsasser N; Scherzad A
Oncol Lett; 2022 Dec; 24(6):450. PubMed ID: 36420071
[TBL] [Abstract][Full Text] [Related]
5. IL-6 antisense-mediated growth inhibition in a head and neck squamous cell carcinoma cell line.
Bran G; Götte K; Riedel K; Hörmann K; Riedel F
In Vivo; 2011; 25(4):579-84. PubMed ID: 21708999
[TBL] [Abstract][Full Text] [Related]
6. PDGF-AA mediates mesenchymal stromal cell chemotaxis to the head and neck squamous cell carcinoma tumor microenvironment.
Watts TL; Cui R; Szaniszlo P; Resto VA; Powell DW; Pinchuk IV
J Transl Med; 2016 Dec; 14(1):337. PubMed ID: 27931212
[TBL] [Abstract][Full Text] [Related]
7. The bidirectional tumor--mesenchymal stromal cell interaction promotes the progression of head and neck cancer.
Kansy BA; Dißmann PA; Hemeda H; Bruderek K; Westerkamp AM; Jagalski V; Schuler P; Kansy K; Lang S; Dumitru CA; Brandau S
Stem Cell Res Ther; 2014 Aug; 5(4):95. PubMed ID: 25115189
[TBL] [Abstract][Full Text] [Related]
8. Adenosine metabolism of human mesenchymal stromal cells isolated from patients with head and neck squamous cell carcinoma.
Schuler PJ; Westerkamp AM; Kansy BA; Bruderek K; Dissmann PA; Dumitru CA; Lang S; Jackson EK; Brandau S
Immunobiology; 2017 Jan; 222(1):66-74. PubMed ID: 26898925
[TBL] [Abstract][Full Text] [Related]
9. p70S6K promotes IL-6-induced epithelial-mesenchymal transition and metastasis of head and neck squamous cell carcinoma.
Wu D; Cheng J; Sun G; Wu S; Li M; Gao Z; Zhai S; Li P; Su D; Wang X
Oncotarget; 2016 Jun; 7(24):36539-36550. PubMed ID: 27174914
[TBL] [Abstract][Full Text] [Related]
10. Irradiated fibroblasts increase interleukin-6 expression and induce migration of head and neck squamous cell carcinoma.
Suzuki S; Toyoma S; Kawasaki Y; Yamada T
PLoS One; 2022; 17(1):e0262549. PubMed ID: 35089951
[TBL] [Abstract][Full Text] [Related]
11. Association between metalloproteinases 2 and 9 activity and ERK1/2 phosphorylation status in head and neck cancers: an ex vivo study.
Garavello W; Maggioni D; Nicolini G; Motta L; Tredici G; Gaini R
Oncol Rep; 2010 Oct; 24(4):1073-8. PubMed ID: 20811691
[TBL] [Abstract][Full Text] [Related]
12. Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-kappaB signal pathways.
Bancroft CC; Chen Z; Dong G; Sunwoo JB; Yeh N; Park C; Van Waes C
Clin Cancer Res; 2001 Feb; 7(2):435-42. PubMed ID: 11234901
[TBL] [Abstract][Full Text] [Related]
13. Adipose-Derived Mesenchymal Stem Cells do not Affect the Invasion and Migration Potential of Oral Squamous Carcinoma Cells.
Sinha S; Narjus-Sterba M; Tuomainen K; Kaur S; Seppänen-Kaijansinkko R; Salo T; Mannerström B; Al-Samadi A
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899628
[TBL] [Abstract][Full Text] [Related]
14. Kallikrein-related peptidase 6 regulates epithelial-to-mesenchymal transition and serves as prognostic biomarker for head and neck squamous cell carcinoma patients.
Schrader CH; Kolb M; Zaoui K; Flechtenmacher C; Grabe N; Weber KJ; Hielscher T; Plinkert PK; Hess J
Mol Cancer; 2015 May; 14():107. PubMed ID: 25990935
[TBL] [Abstract][Full Text] [Related]
15. BCG immune activation reduces growth and angiogenesis in an in vitro model of head and neck squamous cell carcinoma.
Sánchez-Rodríguez C; Cruces KP; Riestra Ayora J; Martín-Sanz E; Sanz-Fernández R
Vaccine; 2017 Nov; 35(47):6395-6403. PubMed ID: 29029943
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells support migration, extracellular matrix invasion, proliferation, and survival of endothelial cells in vitro.
Potapova IA; Gaudette GR; Brink PR; Robinson RB; Rosen MR; Cohen IS; Doronin SV
Stem Cells; 2007 Jul; 25(7):1761-8. PubMed ID: 17395769
[TBL] [Abstract][Full Text] [Related]
17. The paracrine effect of cancer-associated fibroblast-induced interleukin-33 regulates the invasiveness of head and neck squamous cell carcinoma.
Chen SF; Nieh S; Jao SW; Wu MZ; Liu CL; Chang YC; Lin YS
J Pathol; 2013 Oct; 231(2):180-9. PubMed ID: 23775566
[TBL] [Abstract][Full Text] [Related]
18. BMSC enhance the survival of paclitaxel treated squamous cell carcinoma cells in vitro.
Scherzed A; Hackenberg S; Froelich K; Kessler M; Koehler C; Hagen R; Radeloff A; Friehs G; Kleinsasser N
Cancer Biol Ther; 2011 Feb; 11(3):349-57. PubMed ID: 21127403
[TBL] [Abstract][Full Text] [Related]
19. Head and neck cancer triggers increased IL-6 production of CD34+ stem cells from human cord blood.
Nitsch SM; Pries R; Wollenberg B
In Vivo; 2007; 21(3):493-8. PubMed ID: 17591359
[TBL] [Abstract][Full Text] [Related]
20. miR145 targets the SOX9/ADAM17 axis to inhibit tumor-initiating cells and IL-6-mediated paracrine effects in head and neck cancer.
Yu CC; Tsai LL; Wang ML; Yu CH; Lo WL; Chang YC; Chiou GY; Chou MY; Chiou SH
Cancer Res; 2013 Jun; 73(11):3425-40. PubMed ID: 23548270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
